Skip to main content
Livermore
Livermore
ZHEN

ARK Invest

Superinvestor

ARK Investment Management LLC

SEC CIK
0001697748
Manager
Cathie Wood
Style
Growth
Latest filing
Aug 14, 2026

TEVA holding history

Teva Pharmaceutical Industries Ltd in every 13F filed by ARK Invest, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings

Shares (Q2 2026)
68,653
Value
$2.33M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TEVA by ARK Invest, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202668,653$2.33M<0.1%+374+0.5%AddedHolders
Q1 202668,279$2.06M<0.1%−36,852−35.1%ReducedHolders
Q4 2025105,131$3.28M<0.1%−13,590−11.4%ReducedHolders
Q3 2025118,721$2.40M<0.1%−2,153−1.8%ReducedHolders
Q2 2025120,874$2.03M<0.1%+30,621+33.9%AddedHolders
Q1 202590,253$1.39M<0.1%−10,190−10.1%ReducedHolders
Q4 2024100,443$2.21M<0.1%−23,422−18.9%ReducedHolders
Q3 2024123,865$2.23M<0.1%−45,555−26.9%ReducedHolders
Q2 2024169,420$2.75M<0.1%−22,716−11.8%ReducedHolders
Q1 2024192,136$2.71M<0.1%−30,670−13.8%ReducedHolders
Q4 2023222,806$2.33M<0.1%−32,004−12.6%ReducedHolders
Q3 2023254,810$2.60M<0.1%+16,887+7.1%AddedHolders
Q2 2023237,923$1.79M<0.1%+26,145+12.3%AddedHolders
Q1 2023211,778$1.87M<0.1%−47,385−18.3%ReducedHolders
Q4 2022259,163$2.36M<0.1%−76,305−22.7%ReducedHolders
Q3 2022335,468$2.71M<0.1%+102,950+44.3%AddedHolders
Q2 2022232,518$2.12M<0.1%−67,494−22.5%ReducedHolders
Q1 2022300,012$2.82M<0.1%−4,780−1.6%ReducedHolders
Q4 2021304,792$2.44M<0.1%−99,204−24.6%ReducedHolders
Q3 2021403,996$3.94M<0.1%−108,446−21.2%ReducedHolders
Q2 2021512,442$5.07M<0.1%+12,598+2.5%AddedHolders
Q1 2021499,844$5.77M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.